Riskpilot← Back to searchSign inGet full accessElobix AB
ABActiveOrg 5569469421Arvid Wallgrens Backe 20Research and experimental development on natural sciences and engineering · NACE 7210Est. 20130 employees
Revenue 2024
SEK 4M
-96% vs 2023
EBITDA margin
74.9%
-97% vs 2023
Equity ratio
97.8%
Financial strength
Net profit 2024
SEK -614,7M
-585% vs 2023
| Revenue | SEK 4M | -96% |
| EBITDA | SEK 3M | -97% |
| Net profit | SEK -614,7M | -585% |
| Total assets | SEK 13M | -98% |
| Equity | SEK 12,7M | +126% |
| Employees | 0 | — |
Legal name
Elobix AB
Org number
5569469421
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 oktober 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet skall omfatta forskning, utveckling, tillverkning, köp och försäljning av tjänster och produkter av biotekniska och/ eller medicinsk karaktär samt annan förenlig rörelse samt äga och förvalta fast och lös egendom, däribland aktier och andelar i andra företag.
Address
Arvid Wallgrens Backe 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 498 | 102 204 | 90 629 | 70 839 | 162 622 | 99 690 | 105 328 | 4 038 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 39 122 | 94 545 | −2 101 | 88 355 | 48 223 | 38 392 | 165 952 | 99 989 | 103 254 | 3 023 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | −0 |
| EBIT | 39 122 | 94 545 | −2 101 | 88 355 | 48 223 | 38 392 | 165 952 | 99 989 | 103 254 | 3 023 |
| Net financials | −709 | 2 957 | −49 | −84 290 | −83 521 | −98 989 | −362 994 | −436 208 | −149 685 | 9 629 |
| Profit before tax | 0 | 5 | −2 150 | 2 140 | −78 878 | −95 467 | −103 003 | −118 114 | −89 784 | −614 675 |
| Tax | −0 | −5 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | −2 150 | 2 140 | −78 878 | −95 467 | −103 003 | −118 114 | −89 784 | −614 675 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 44 865 | 2 952 | 3 238 | 464 392 | 527 914 | 586 312 | 668 502 | 593 309 | 629 318 | 13 035 |
| Equity | 50 | 51 | −2 100 | 40 | 87 | 32 400 | 16 856 | −101 259 | −48 392 | 12 749 |
| Long-term debt | 0 | 0 | 0 | 453 499 | 457 882 | 527 787 | 546 987 | 665 272 | 622 916 | 0 |
| Short-term debt | 44 815 | 2 901 | 5 337 | 10 853 | 69 945 | 26 125 | 104 660 | 29 296 | 54 794 | 287 |
| Total debt | 44 815 | 2 901 | 5 337 | 464 352 | 527 827 | 553 912 | 651 647 | 694 568 | 677 710 | 287 |
EBITDA margin
74.9%
This company
15.8%
Market median
+374% vs market
20152024
Equity ratio
97.8%
This company
38.2%
Market median
+156% vs market
20152024
Return on equity
-4821.4%
This company
18.4%
Market median
-26303% vs market
20152024
Net profit margin
-15222.3%
This company
8.1%
Market median
-188030% vs market
20152024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20152024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SA Chief Auditor | Chief Auditor | 2024 | — | — |
MG Chief Auditor | Chief Auditor | 2020 | — | — |
AS Chief Auditor | Chief Auditor | 2024 | — | — |
NE Chief Auditor | Chief Auditor | 2020 | — | — |
JD Chief Auditor | Chief Auditor | 2025 | — | — |
JP Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Albireo AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ALBIREO PHARMA INC
Elobix AB Board members of Elobix AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simon Alexander Jancke | Chief Auditor | 0 companies |
| Mattias Gustaf Erik Olofson | Chief Auditor | 0 companies |
| Anita Santa | Chief Auditor | 0 companies |
| Nina Elisabeth Bergman | Chief Auditor | 0 companies |
| Johan Daniel Haglund | Chief Auditor | 0 companies |
| Jan Peter Mattsson | Chief Executive Officer | 0 companies |
| Julien Darrigade | Board of Directors | 0 companies |
| Francois Maurice Henri Louis Garnier | Chairman | 0 companies |
| Christelle Evelyne Josselyne Huguet | Board of Directors | 0 companies |
| Howard Bernard Mayer | Board of Directors | 0 companies |
| Peter Dag Åkerblad | Board of Directors | 0 companies |
| Erik Allen Lindström | Board of Directors | 0 companies |
| David, John Chiswell | Chairman | 0 companies |
| Jennie Maria Blomquist | Board of Directors | 0 companies |
| Caroline Sitbon | Chairman | 0 companies |